$1.510
0.000 (0.00%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RNAZ por análisis de gráficos similares
Alphio's RNAZ stock price prediction model matches the current Transcode Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.51 (+0.10%). The 1-week path is $1.53 (+1.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Transcode Therapeutics Inc?
Transcode Therapeutics Inc (RNAZ) is not a good buy right now due to its extremely low RSI of 25.149, indicating oversold conditions, and a staggering year-to-date change of -79.59%. The stock is currently trading at $1.51, significantly below its 52-week high of $12.60, which suggests a lack of investor confidence and potential for further declines. The main risk is its negative earnings trend, with a net income loss of -$19,510,296 in Q1 2026, which raises concerns about its financial viability.
RNAZ cerró en $1.51 el Friday, tras subir 0.00%
Transcode Therapeutics Inc (RNAZ) last closed at $1.51, gaining +0.00%. These facts feed the 1-day and 1-week RNAZ price prediction above.
Factores de la previsión
Los factores de la previsión de Transcode Therapeutics Inc (RNAZ) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RNAZ, ordenadas por similitud.
Análisis de estacionalidad de RNAZ
Historically the probability of a positive November return for RNAZ is 0.00%. February offers the highest probability of a positive month at 60.34%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de RNAZ
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $11.60 | $11.70 | $13.54 | +674.54% |
| Dec 2026 | $10.48 | $12.00 | $12.58 | +694.87% |
En 2026, se proyecta que Transcode Therapeutics Inc (RNAZ) oscile entre $10.48 y $13.54.
Previsión mensual de Transcode Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Transcode Therapeutics Inc promedie $11.70, con un mínimo de $11.60 y un máximo de $13.54.
En Dec de 2026, se proyecta que Transcode Therapeutics Inc promedie $12.00, con un mínimo de $10.48 y un máximo de $12.58.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.